Difference between revisions of "Team:SDU-Denmark/Description"

 
(7 intermediate revisions by the same user not shown)
Line 15: Line 15:
 
<!------------------------content ---------------->
 
<!------------------------content ---------------->
 
<h3>Bacto-Aid</h3>
 
<h3>Bacto-Aid</h3>
 +
<p>This project was chosen due to the interest in synthetic spider silk. An article of interest concluded that synthetic spider silk fused to human defensins was stable while preserving the antimicrobial effect of the defensins, thus it became one of the founding pillars of our project <span class="tooltip"><span class="tooltiptext"><a target="blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081935/">Gomes, Silvia C, Isabel B Leonor, Joao F Mano, Rui L Reis og David L Kaplan (2011). “Antimicrobial functionalized genetically engineered spider silk.” eng. I: <i>Bio- materials</i> 32.18, s. 4255–4266. issn: 1878- 5905</a><</span></span>. The idea of making PHB a part of our project as the plastic in the bandage, evolved from the desire to solve the growing problem of plastic pollution. Bacto-Aid was the perfect project to make our two wishes come to life.</p><br>
 
<p>The three major subparts of our project are thoroughly described in the following sections.</p><br>
 
<p>The three major subparts of our project are thoroughly described in the following sections.</p><br>
  
 
<p> <img src="https://static.igem.org/mediawiki/2016/e/e9/T--SDU-Denmark--minibacto.png" width="5%" style="display:inline-block;margin-right:5px;">The bacteriocins
 
<p> <img src="https://static.igem.org/mediawiki/2016/e/e9/T--SDU-Denmark--minibacto.png" width="5%" style="display:inline-block;margin-right:5px;">The bacteriocins
are the antimicrobial peptides in our hybrid silk. Resistance development has been creating difficulties in treating infections with traditional antibiotics. The use of bacteriocins could relieve some of the resistance pressure, paving a way for an alternative treatment. The bacteriocins act as bactericidal peptides through pore formation and interference with intracellular enzymatic reactions of specific target bacteria. Bacteriocins are essentially proteins that have bactericidal effect on specific strains. Today it is not used as an therapeutical antimicrobial compound, as it would be denatured in the stomach. Intravenous administration has been tested in mouse and shows promising results <span class="tooltip"><span class="tooltiptext"><a target="blank" href="2016.igem.org/Team:SDU-Denmark/Attributions#articles">Lohans, C. T., & Vederas, J. C. (2012). Development of Class IIa Bacteriocins as Therapeutic Agents. International Journal of Microbiology, 2012, 13. doi:10.1155/2012/386410</a><</span></span>. Because proteins are translated from genes we can express  desirable proteins in series. This allows us to incorporate bacteriocin proteins in between silk proteins. We, and <a target="blank" href="https://2016.igem.org/Team:Stockholm">the iGEM team of Stockholm</a>, performed a <a target="blank" href="https://2016.igem.org/Team:SDU-Denmark/Demonstrate#effect">MIC-test</a> to observe the effect of our bacteriocins towards resistant bacteria. According to the test, the bacteriocins were proven to be quite effective. <a target="blank" href="https://2016.igem.org/Team:SDU-Denmark/Bacteriocins"> For further information about bacteriocins, read here</a>.</p><br>
+
are the antimicrobial peptides in our hybrid silk. Resistance development has been creating difficulties in treating infections with traditional antibiotics. Since no resistance has been observed against bacteriocins that have been used the past 50 years, they show great potential as an alternative treatment. The bacteriocins act bactericidally through pore formation and interfere with intracellular enzymatic reactions of the specific targeted bacteria <span class="tooltip"><span class="tooltiptext"><a target="blank" href="2016.igem.org/Team:SDU-Denmark/Attributions#articles">Zendo, T., Yoneyama, F., & Sonomoto, K. (2010). Lactococcal membrane-permeabilizing antimicrobial peptides.</a><</span></span>. Bacteriocins are proteins, but are not used today for therapeutical use due the denaturation in the stomach. Intravenous administration has been tested in vivo and shows promising results <span class="tooltip"><span class="tooltiptext"><a target="blank" href="2016.igem.org/Team:SDU-Denmark/Attributions#articles">Lohans, C. T., & Vederas, J. C. (2012). Development of Class IIa Bacteriocins as Therapeutic Agents. International Journal of Microbiology, 2012, 13. doi:10.1155/2012/386410</a><</span></span>. As both bacteriocins and silk are proteins, we can incorporate bacteriocins into the silk polymer through gene-manipulation. We, and <a target="blank" href="https://2016.igem.org/Team:Stockholm">the iGEM team of Stockholm</a>, performed <a target="blank" href="https://2016.igem.org/Team:SDU-Denmark/Demonstrate#effect">MIC-tests</a> to quantify the effect of our bacteriocins against resistant pathogenic bacteria. The tests show that purified bacteriocins were quite effective as growth inhibitors. <a target="blank" href="https://2016.igem.org/Team:SDU-Denmark/Bacteriocins"> For further information about bacteriocins, read here</a>.</p><br>
  
<p> <img src="https://static.igem.org/mediawiki/2016/4/45/T--SDU-Denmark--minisilk.png" width="5%" style="display:inline-block;margin-right:5px;">The spider silk is chosen due to its angiogenic properties and proliferative effect on keratinocytes (skin cells)<span class="tooltip"><span class="tooltiptext"><a target="blank" href="2016.igem.org/Team:SDU-Denmark/Attributions#articles">Fredriksson, C., Hedhammar, M., Feinstein, R., Nordling, K., Kratz, G., Johansson, J., . . . Rising, A. (2009). <i>Tissue Response to Subcutaneously Implanted Recombinant Spider Silk: An in Vivo Study.</i> Materials, 2(4), 1908.</a><</span></span>., which is not seen in the traditional used gauze. The silk is produced by <i>Nephila Clavipes</i> made from repetitive protein expression of the dragline silk proteins. In order to obtain the ability to create silk , similar functions must be applicated to the <i>E. Coli</i>. Repetitive sequences of the genes MaSp1 and MaSp2 must be inserted into the plasmid of <i>E. Coli</i>. Synthesizing repetitive sequences are troublesome, and is difficult to do through 3A assembly, due to multiple scar-sites. To avoid scar sites, we tried to synthesize the silk with the help of the protocols provided by the <a target="blank" href="https://2015.igem.org/Team:UCLA">2015 iGEM team from UCLA</a>, because they had already succeeded in producing spider silk from bacteria. The method gives way for hybrid silk, which consists of bacteriocins and spider silk with the same method. <a target="blank" href="https://2016.igem.org/Team:SDU-Denmark/Silk"> For further information about the spider silk, read here</a>. </p><br>
+
<p> <img src="https://static.igem.org/mediawiki/2016/4/45/T--SDU-Denmark--minisilk.png" width="5%" style="display:inline-block;margin-right:5px;">Spider silk was chosen due to its angiogenic properties and proliferative effect on keratinocytes (skin cells), which is not seen in the traditional used gauze <span class="tooltip"><span class="tooltiptext"><a target="blank" href="2016.igem.org/Team:SDU-Denmark/Attributions#articles">Fredriksson, C., Hedhammar, M., Feinstein, R., Nordling, K., Kratz, G., Johansson, J., . . . Rising, A. (2009). <i>Tissue Response to Subcutaneously Implanted Recombinant Spider Silk: An in Vivo Study.</i> Materials, 2(4), 1908.</a><</span></span>. The silk is produced natively by <i>Nephila clavipes</i> via repetitive coding sequences of the major silk components, MaSp1 and MaSp2 (Major Spidroin 1 and 2). In order to obtain the ability to create silk, these repetitive regions have been introduced into the <i>E. coli</i> via a plasmid. Synthesizing repetitive sequences are troublesome, and is difficult to do through the iGEM standard 3A assembly, due to multiple scar-sites. To avoid scar-sites we tried to synthesize the silk with the protocols provided by the <a target="blank" href="https://2015.igem.org/Team:UCLA">2015 iGEM team from UCLA</a>, because they succeeded in producing spider silk from bacteria. The method allows the creation of a hybrid silk consisting of bacteriocins and spider silk. <a target="blank" href="https://2016.igem.org/Team:SDU-Denmark/Silk"> For further information about the spider silk, read here</a>. </p><br>
  
<p> <img src="https://static.igem.org/mediawiki/2016/8/87/T--SDU-Denmark--miniPHB.png" width="5%" style="display:inline-block;margin-right:5px;">Poly-β-hydroxybutyrate (PHB) is a biosynthesized polyester, belonging to a group of bio-degradable plastics called polyalkanoates (PHA). PHB is non-toxic and has a high oxygen-permeability <span class="tooltip"><span class="tooltiptext"><a target="blank" href="2016.igem.org/Team:SDU-Denmark/Attributions#articles">JAMBUNATHAN, P. & ZHANG, K. C. 2016. Engineered biosynthesis of biodegradable polymers. <i>Journal of Industrial Microbiology & Biotechnology</i>, 43, 1037-1058.</a><</span></span>. The combination of different promoters and ribosomal binding sites has previously been shown to positively affect the yield of PHB. The yield has further been increased by the introduction of the pantothenate kinase BioBrick. By introducing a PHB secretion system into an <i>E. coli</i> plasmid we can achieve a production of PHB from the existing plastic producing BioBricks, that has left us with enough PHB to 3D print a part of a human jaw. The secretion system we introduce, use phasin as a transportermolecule for the secretion of PHB. Phasin binds to PHA's <span class="tooltip"><span class="tooltiptext"><a href="https://www.ncbi.nlm.nih.gov/pubmed/17074898">Hanisch, J., et al. (2006). "The Ralstonia eutropha H16 phasin PhaP1 is targeted to intracellular triacylglycerol inclusions in Rhodococcus opacus PD630 and Mycobacterium smegmatis mc2155, and provides an anchor to target other proteins." Microbiology 152(Pt 11): 3271-3280.</a></span></span>, which creates the possibility of its use when working with other types of bio-degradable PHA polyesters in bacteria. <a target="blank" href="https://2016.igem.org/Team:SDU-Denmark/PHB">For further information about PHB, read here</a>.</p><br>
+
<p> <img src="https://static.igem.org/mediawiki/2016/8/87/T--SDU-Denmark--miniPHB.png" width="5%" style="display:inline-block;margin-right:5px;">Poly-β-hydroxybutyrate (PHB) is a biosynthesized polyester, belonging to a group of biodegradable plastics called polyalkanoates (PHA). PHB is non-toxic and has a high oxygen-permeability <span class="tooltip"><span class="tooltiptext"><a target="blank" href="2016.igem.org/Team:SDU-Denmark/Attributions#articles">JAMBUNATHAN, P. & ZHANG, K. C. 2016. Engineered biosynthesis of biodegradable polymers. <i>Journal of Industrial Microbiology & Biotechnology</i>, 43, 1037-1058.</a><</span></span>. The combination of different promoters and ribosomal binding sites have previously been shown to positively affect the yield of PHB. The yield has further been increased by the introduction of the pantothenate kinase BioBrick. By introducing a PHB secretion system into an <i>E. coli</i> strain, we can possibly achieve a continuous production of PHB from the existing plastic producing BioBricks. Our system has already left us with enough PHB to 3D print a part of a human jaw. The secretion system we introduce, use phasin as a transportermolecule for the secretion of PHB. Phasin binds to PHAs, which creates the possibility of its use when working with other types of biodegradable PHA polyesters in bacteria <span class="tooltip"><span class="tooltiptext"><a href="https://www.ncbi.nlm.nih.gov/pubmed/17074898">Hanisch, J., et al. (2006). "The Ralstonia eutropha H16 phasin PhaP1 is targeted to intracellular triacylglycerol inclusions in Rhodococcus opacus PD630 and Mycobacterium smegmatis mc2155, and provides an anchor to target other proteins." Microbiology 152(Pt 11): 3271-3280.</a></span></span>. <a target="blank" href="https://2016.igem.org/Team:SDU-Denmark/PHB">For further information about PHB, read here</a>.</p><br>  
 
+
<p>This project was chosen due to the interest in synthetic spider silk. An article of interest that concluded antimicrobial effect of fused synthetic spider silk to human defenses became the pillar of our project <span class="tooltip"><span class="tooltiptext"><a target="blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081935/">Gomes, Silvia C, Isabel B Leonor, Joao F Mano, Rui L Reis og David L Kaplan (2011). “Antimicrobial functionalized gene- tically engineered spider silk.” eng. I: <i>Bio- materials</i> 32.18, s. 4255–4266. issn: 1878- 5905</a><</span></span>. The idea of making PHB a part of our project as the plastic in the bandage, evolved from the desire to have an influence on solving the growing problem of plastic pollution. Bacto-Aid was the perfect project to make our two wishes come to life.</p><br>
+
  
 
<p>In the field of science, scientific reproduction is one of the most important aspects when confirming a hypothesis or theory. iGEM follows this specific scientific virtue by making it a part of both the bronze and gold criteria: the demands imply working with other team’s work. We took it further trying to reproduce parts of earlier iGEM team’s work: <a target="blank" href="https://2015.igem.org/Team:UCLA">the 2015 UCLA team</a>, <a target="blank" href="https://2012.igem.org/Team:Tokyo_Tech">the 2012 Tokyo Tech team</a>, <a target="blank" href="https://2014.igem.org/Team:Imperial">the 2013 Imperial College London</a> and <a target="blank" href="https://2015.igem.org/Team:Stanford-Brown">the 2015 Standford Brown team</a>.</p>
 
<p>In the field of science, scientific reproduction is one of the most important aspects when confirming a hypothesis or theory. iGEM follows this specific scientific virtue by making it a part of both the bronze and gold criteria: the demands imply working with other team’s work. We took it further trying to reproduce parts of earlier iGEM team’s work: <a target="blank" href="https://2015.igem.org/Team:UCLA">the 2015 UCLA team</a>, <a target="blank" href="https://2012.igem.org/Team:Tokyo_Tech">the 2012 Tokyo Tech team</a>, <a target="blank" href="https://2014.igem.org/Team:Imperial">the 2013 Imperial College London</a> and <a target="blank" href="https://2015.igem.org/Team:Stanford-Brown">the 2015 Standford Brown team</a>.</p>
  
<h5>Why should consumers care?</h5>
 
 
<div>
 
<div style="float:right;width:40%;">
 
<!--SELVE BILLEDET-->
 
<a href="#market"><img src="https://static.igem.org/mediawiki/2016/9/92/T--SDU-Denmark--market.png" alt="" width="100%" style="padding-left:15px;"></a>
 
<!--SELVE BILLEDET SLUT-->
 
 
<div id="market" class="modalDialog" style="overflow: auto;max-height: 100vh;">
 
<div>
 
<a href="#closepop" title="Close" class="closepop">X</a>
 
<img src="https://static.igem.org/mediawiki/2016/9/92/T--SDU-Denmark--market.png" alt="" width="100%">
 
</div>
 
</div>
 
</div><!--end float-->
 
<p>When designing our Bacto-Aid, it was important for us to ensure that Bacto-Aid consists of sustainable and renewable materials. The following survey shows, that Environmental friendly products are favored by 75 % of the consumers. With this in mind, our product satisfy the general opinion of the consumers.</p>
 
</div>
 
  
  

Latest revision as of 00:06, 20 October 2016

Description


Bacto-Aid

This project was chosen due to the interest in synthetic spider silk. An article of interest concluded that synthetic spider silk fused to human defensins was stable while preserving the antimicrobial effect of the defensins, thus it became one of the founding pillars of our project Gomes, Silvia C, Isabel B Leonor, Joao F Mano, Rui L Reis og David L Kaplan (2011). “Antimicrobial functionalized genetically engineered spider silk.” eng. I: Bio- materials 32.18, s. 4255–4266. issn: 1878- 5905<. The idea of making PHB a part of our project as the plastic in the bandage, evolved from the desire to solve the growing problem of plastic pollution. Bacto-Aid was the perfect project to make our two wishes come to life.


The three major subparts of our project are thoroughly described in the following sections.


The bacteriocins are the antimicrobial peptides in our hybrid silk. Resistance development has been creating difficulties in treating infections with traditional antibiotics. Since no resistance has been observed against bacteriocins that have been used the past 50 years, they show great potential as an alternative treatment. The bacteriocins act bactericidally through pore formation and interfere with intracellular enzymatic reactions of the specific targeted bacteria Zendo, T., Yoneyama, F., & Sonomoto, K. (2010). Lactococcal membrane-permeabilizing antimicrobial peptides.<. Bacteriocins are proteins, but are not used today for therapeutical use due the denaturation in the stomach. Intravenous administration has been tested in vivo and shows promising results Lohans, C. T., & Vederas, J. C. (2012). Development of Class IIa Bacteriocins as Therapeutic Agents. International Journal of Microbiology, 2012, 13. doi:10.1155/2012/386410<. As both bacteriocins and silk are proteins, we can incorporate bacteriocins into the silk polymer through gene-manipulation. We, and the iGEM team of Stockholm, performed MIC-tests to quantify the effect of our bacteriocins against resistant pathogenic bacteria. The tests show that purified bacteriocins were quite effective as growth inhibitors. For further information about bacteriocins, read here.


Spider silk was chosen due to its angiogenic properties and proliferative effect on keratinocytes (skin cells), which is not seen in the traditional used gauze Fredriksson, C., Hedhammar, M., Feinstein, R., Nordling, K., Kratz, G., Johansson, J., . . . Rising, A. (2009). Tissue Response to Subcutaneously Implanted Recombinant Spider Silk: An in Vivo Study. Materials, 2(4), 1908.<. The silk is produced natively by Nephila clavipes via repetitive coding sequences of the major silk components, MaSp1 and MaSp2 (Major Spidroin 1 and 2). In order to obtain the ability to create silk, these repetitive regions have been introduced into the E. coli via a plasmid. Synthesizing repetitive sequences are troublesome, and is difficult to do through the iGEM standard 3A assembly, due to multiple scar-sites. To avoid scar-sites we tried to synthesize the silk with the protocols provided by the 2015 iGEM team from UCLA, because they succeeded in producing spider silk from bacteria. The method allows the creation of a hybrid silk consisting of bacteriocins and spider silk. For further information about the spider silk, read here.


Poly-β-hydroxybutyrate (PHB) is a biosynthesized polyester, belonging to a group of biodegradable plastics called polyalkanoates (PHA). PHB is non-toxic and has a high oxygen-permeability JAMBUNATHAN, P. & ZHANG, K. C. 2016. Engineered biosynthesis of biodegradable polymers. Journal of Industrial Microbiology & Biotechnology, 43, 1037-1058.<. The combination of different promoters and ribosomal binding sites have previously been shown to positively affect the yield of PHB. The yield has further been increased by the introduction of the pantothenate kinase BioBrick. By introducing a PHB secretion system into an E. coli strain, we can possibly achieve a continuous production of PHB from the existing plastic producing BioBricks. Our system has already left us with enough PHB to 3D print a part of a human jaw. The secretion system we introduce, use phasin as a transportermolecule for the secretion of PHB. Phasin binds to PHAs, which creates the possibility of its use when working with other types of biodegradable PHA polyesters in bacteria Hanisch, J., et al. (2006). "The Ralstonia eutropha H16 phasin PhaP1 is targeted to intracellular triacylglycerol inclusions in Rhodococcus opacus PD630 and Mycobacterium smegmatis mc2155, and provides an anchor to target other proteins." Microbiology 152(Pt 11): 3271-3280.. For further information about PHB, read here.


In the field of science, scientific reproduction is one of the most important aspects when confirming a hypothesis or theory. iGEM follows this specific scientific virtue by making it a part of both the bronze and gold criteria: the demands imply working with other team’s work. We took it further trying to reproduce parts of earlier iGEM team’s work: the 2015 UCLA team, the 2012 Tokyo Tech team, the 2013 Imperial College London and the 2015 Standford Brown team.